Published in Am Fam Physician on November 01, 2002
Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex. J Biol Chem (2011) 0.99
Managing ophthalmic herpes zoster in primary care. BMJ (2005) 0.92
Herpes Zoster Ophthalmicus in HIV/AIDS. Community Eye Health (2003) 0.85
A case of optic neuritis complicating herpes zoster ophthalmicus in a child. Korean J Ophthalmol (2010) 0.82
Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone. Ocul Surf (2015) 0.81
Antiviral activity of salivary microRNAs for ophthalmic herpes zoster. Theor Biol Med Model (2012) 0.78
Nose: Applied Aspects in Dermatology. Indian J Dermatol (2016) 0.75
Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy. PLoS One (2015) 0.75
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
Herpes zoster ophthalmicus. West J Emerg Med (2008) 0.75
Information from your family doctor. What you should know about HZO. Am Fam Physician (2002) 0.75
Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol (2009) 1.52
A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology (2009) 1.50
Design and fabrication of an artificial cornea based on a photolithographically patterned hydrogel construct. Biomed Microdevices (2007) 1.38
Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol (2005) 1.21
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol (2004) 1.12
A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol (2007) 1.04
Toward the development of an artificial cornea: improved stability of interpenetrating polymer networks. J Biomed Mater Res B Appl Biomater (2011) 1.02
Progress in the development of interpenetrating polymer network hydrogels. Polym Adv Technol (2008) 1.02
Glucose-permeable interpenetrating polymer network hydrogels for corneal implant applications: a pilot study. Curr Eye Res (2008) 0.99
Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol (2005) 0.99
Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol (2003) 0.98
Development of hydrogel-based keratoprostheses: a materials perspective. Biotechnol Prog (2008) 0.95
Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery. Eur J Ophthalmol (2012) 0.94
Glucose permeability of human, bovine, and porcine corneas in vitro. Ophthalmic Res (2006) 0.91
Prevention and treatment of injection-related endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2014) 0.88
Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology (2010) 0.87
Morphology of Photopolymerized End-linked Poly(ethylene glycol) Hydrogels by Small Angle X-ray Scattering. Macromolecules (2010) 0.86
Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina (2008) 0.85
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. Graefes Arch Clin Exp Ophthalmol (2005) 0.83
Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology (2004) 0.83
Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing. J Biomed Mater Res A (2009) 0.82
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis. Retina (2008) 0.82
Comparison of preoperative conjunctival bacterial flora in patients undergoing glaucoma or cataract surgery. J Glaucoma (2004) 0.81
Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. J Cataract Refract Surg (2002) 0.81
Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination. Cornea (2011) 0.81
Rapid direct antibiotic susceptibility testing in endophthalmitis. Ophthalmology (2002) 0.81
Aspergillus fumigatus keratitis following laser in situ keratomileusis. J Cataract Refract Surg (2007) 0.80
Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. J Ocul Pharmacol Ther (2009) 0.80
In vivo biocompatibility of two PEG/PAA interpenetrating polymer networks as corneal inlays following deep stromal pocket implantation. J Mater Sci Mater Med (2013) 0.79
Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology (2008) 0.79
Endophthalmitis prophylaxis. Ophthalmol Clin North Am (2006) 0.79
Prevention of postcataract endophthalmitis: evidence-based medicine. Curr Opin Ophthalmol (2012) 0.79
A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.77
One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus. J Cataract Refract Surg (2009) 0.77
Normal ocular flora in newborns delivered in two hospital centers in Argentina and Paraguay. Graefes Arch Clin Exp Ophthalmol (2005) 0.76
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2004) 0.75
Use of rapid antibiotic susceptibility testing in bacterial endophthalmitis. Retina (2005) 0.75
Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin. Graefes Arch Clin Exp Ophthalmol (2003) 0.75
Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery. J Cataract Refract Surg (2008) 0.75
Diffusion of protein through the human cornea. Ophthalmic Res (2012) 0.75
Intravenous imipenem prophylaxis in experimental endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2002) 0.75
Interpenetrating polymer network hydrogel scaffolds for artificial cornea periphery. J Mater Sci Mater Med (2015) 0.75
Nodular scleritis in a patient with pyoderma gangrenosum. Arch Ophthalmol (2002) 0.75
Successful DMEK after intraoperative graft inversion. Cornea (2015) 0.75